Gain Therapeutics, Inc. — Investor Relations & Filings
Gain Therapeutics, Inc. is a clinical-stage biotechnology company that discovers and develops next-generation allosteric small molecule therapies. The company utilizes its proprietary Magellan™ drug discovery platform, which combines artificial intelligence with physics-based computational models to identify novel allosteric binding sites on disease-implicated proteins. This approach aims to modulate protein function to treat diseases that are currently undruggable. The company's lead candidate, GT-02287, is in Phase I clinical trials for the treatment of GBA-Parkinson’s disease. Gain's therapeutic pipeline targets neurodegenerative diseases, lysosomal storage disorders, and other conditions with high unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-26 | English | |
| DEF 14A - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-04-28 | English | |
| 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | |
| 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | |
| 8-K - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-03-18 | English | |
| 8-K Filing | 2026-02-03 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 47063407 | FORM 8-K | 2026-05-26 | English | ||
| 38172661 | DEF 14A - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-04-28 | English | ||
| 33053358 | 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | ||
| 33053356 | 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | ||
| 32975364 | 8-K - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-03-18 | English | ||
| 31868801 | 8-K Filing | 2026-02-03 | English | ||
|
2025
9 filings
| |||||
| 13280065 | FORM 8-K | 2025-12-18 | English | ||
| 13280066 | FORM S-8 | 2025-12-03 | English | ||
| 13280067 | FORM 8-K | 2025-11-28 | English | ||
| 13280068 | 424B5 | 2025-11-28 | English | ||
| 13280071 | 10-Q | 2025-11-12 | English | ||
| 13280070 | 8-K | 2025-11-12 | English | ||
| 13280069 | S-3/A | 2025-11-07 | English | ||
| 13280072 | FORM 8-K | 2025-10-14 | English | ||
| 13280073 | FORM 8-K | 2025-10-09 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
Gain Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34440/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34440 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34440 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34440 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34440}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Gain Therapeutics, Inc. (id: 34440)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.